Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Zier

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Cytokines and Molecular Therapy|September 1, 1996
Gene therapy with modified tumor cells enables T-cell activation by stimulating pathways required for signal transductionS Salvadori, K Zier
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1996
Molecular basis of T cell dysfunction in cancer is influenced by the paracrine secretion of tumor-derived IL-2S Salvadori, K Zier
Academic Medicine : Journal of the Association of American Medical Colleges|July 13, 2001
A multifaceted program to encourage medical students' researchK Zier, A Stagnaro-Green
Cancer Gene Therapy|September 1, 1994
Functional defects are associated with abnormal signal transduction in T cells of mice inoculated with parental but not IL-2 secreting tumor cellsS Salvadori, B Gansbacher, K Zier
Cellular Immunology|May 14, 1998
Antigen presentation by B7-nonprofessional APC does not prevent responses to solid tumor cellsS Salvadori, T Moran, K Zier
Journal of Immunology (Baltimore, Md. : 1950)|February 5, 2000
Resection of solid tumors reverses T cell defects and restores protective immunityS Salvadori, G Martinelli, K Zier
Scandinavian Journal of Immunology|January 1, 1980
Priming against stimulator-derived alloantigens bound onto MLC-activated blastsB Gänsbacher, K Zier, E D Albert
Autoimmunity|January 1, 1989
Expression of HLA-DR mRNA in T cells following activation is early and can precede DNA synthesisK Zier, B Gansbacher, N Ikegaki, et al.
Blut|December 1, 1982
[Density distribution of human lymphocytes. I. Results of research on normal lymphoid tissue]C Huber, D Niederwieser, G Gastl, et al.
Human Gene Therapy|October 1, 1995
B7-1 amplifies the response to interleukin-2-secreting tumor vaccines in vivo, but fails to induce a response by naive cells in vitroS Salvadori, B Gansbacher, I Wernick, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Cytokines and Molecular Therapy|September 1, 1996
Gene therapy with modified tumor cells enables T-cell activation by stimulating pathways required for signal transductionS Salvadori, K Zier
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1996
Molecular basis of T cell dysfunction in cancer is influenced by the paracrine secretion of tumor-derived IL-2S Salvadori, K Zier
Academic Medicine : Journal of the Association of American Medical Colleges|July 13, 2001
A multifaceted program to encourage medical students' researchK Zier, A Stagnaro-Green
Cancer Gene Therapy|September 1, 1994
Functional defects are associated with abnormal signal transduction in T cells of mice inoculated with parental but not IL-2 secreting tumor cellsS Salvadori, B Gansbacher, K Zier
Cellular Immunology|May 14, 1998
Antigen presentation by B7-nonprofessional APC does not prevent responses to solid tumor cellsS Salvadori, T Moran, K Zier
Journal of Immunology (Baltimore, Md. : 1950)|February 5, 2000
Resection of solid tumors reverses T cell defects and restores protective immunityS Salvadori, G Martinelli, K Zier
Scandinavian Journal of Immunology|January 1, 1980
Priming against stimulator-derived alloantigens bound onto MLC-activated blastsB Gänsbacher, K Zier, E D Albert
Autoimmunity|January 1, 1989
Expression of HLA-DR mRNA in T cells following activation is early and can precede DNA synthesisK Zier, B Gansbacher, N Ikegaki, et al.
Blut|December 1, 1982
[Density distribution of human lymphocytes. I. Results of research on normal lymphoid tissue]C Huber, D Niederwieser, G Gastl, et al.
Human Gene Therapy|October 1, 1995
B7-1 amplifies the response to interleukin-2-secreting tumor vaccines in vivo, but fails to induce a response by naive cells in vitroS Salvadori, B Gansbacher, I Wernick, et al.
Pageof 2